Royce & Associates LP cut its holdings in RTI Surgical, Inc. (NASDAQ:RTIX) by 9.8% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 648,155 shares of the medical equipment provider’s stock after selling 70,500 shares during the quarter. Royce & Associates LP owned 1.12% of RTI Surgical worth $3,792,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in RTIX. Wedge Capital Management L L P NC purchased a new stake in shares of RTI Surgical in the 2nd quarter worth $1,471,000. Kennedy Capital Management Inc. increased its stake in shares of RTI Surgical by 20.0% in the 1st quarter. Kennedy Capital Management Inc. now owns 1,422,371 shares of the medical equipment provider’s stock worth $5,689,000 after purchasing an additional 236,923 shares in the last quarter. Paradigm Capital Management Inc. NY increased its stake in shares of RTI Surgical by 3.7% in the 1st quarter. Paradigm Capital Management Inc. NY now owns 5,833,270 shares of the medical equipment provider’s stock worth $23,333,000 after purchasing an additional 208,200 shares in the last quarter. Renaissance Technologies LLC increased its stake in shares of RTI Surgical by 12.6% in the 1st quarter. Renaissance Technologies LLC now owns 758,900 shares of the medical equipment provider’s stock worth $3,036,000 after purchasing an additional 84,700 shares in the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in RTI Surgical by 2.0% in the 1st quarter. Dimensional Fund Advisors LP now owns 3,900,031 shares of the medical equipment provider’s stock worth $15,600,000 after buying an additional 74,933 shares in the last quarter. 69.99% of the stock is currently owned by hedge funds and other institutional investors.
In other news, Director Nicholas J. Valeriani bought 5,500 shares of RTI Surgical stock in a transaction that occurred on Monday, August 21st. The stock was purchased at an average cost of $4.70 per share, with a total value of $25,850.00. Following the completion of the transaction, the director now directly owns 47,754 shares in the company, valued at $224,443.80. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP John N. Varela bought 12,000 shares of RTI Surgical stock in a transaction that occurred on Friday, August 11th. The stock was purchased at an average cost of $4.85 per share, with a total value of $58,200.00. Following the completion of the transaction, the executive vice president now owns 47,998 shares of the company’s stock, valued at $232,790.30. The disclosure for this purchase can be found here. 4.90% of the stock is owned by company insiders.
Shares of RTI Surgical, Inc. (NASDAQ RTIX) opened at 4.60 on Monday. The firm has a 50-day moving average of $4.77 and a 200 day moving average of $4.74. RTI Surgical, Inc. has a 52 week low of $2.50 and a 52 week high of $6.00. The company’s market cap is $271.56 million.
RTI Surgical (NASDAQ:RTIX) last announced its earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.02. RTI Surgical had a positive return on equity of 2.07% and a negative net margin of 6.53%. The firm had revenue of $72.10 million during the quarter, compared to analysts’ expectations of $70.25 million. The business’s revenue was up 6.7% compared to the same quarter last year. Equities analysts expect that RTI Surgical, Inc. will post $0.06 EPS for the current fiscal year.
A number of equities research analysts have issued reports on RTIX shares. BidaskClub downgraded shares of RTI Surgical from a “strong-buy” rating to a “buy” rating in a report on Tuesday, July 25th. ValuEngine raised shares of RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. Finally, Zacks Investment Research downgraded shares of RTI Surgical from a “buy” rating to a “hold” rating in a report on Thursday, June 29th.
COPYRIGHT VIOLATION NOTICE: “Royce & Associates LP Lowers Stake in RTI Surgical, Inc. (NASDAQ:RTIX)” was published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are accessing this story on another website, it was illegally stolen and republished in violation of US & international copyright and trademark law. The correct version of this story can be read at https://ledgergazette.com/2017/09/25/royce-associates-lp-sells-70500-shares-of-rti-surgical-inc-rtix.html.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.